01273 704473

info@novuscomms.com

01273 704473

info@novuscomms.com

#HVO hVIVO plc- Share Price November 11, 2022 – Posted in: hVIVO (HVO)

hVIVO plc (AIM: HVO) (formerly Open Orphan plc), a rapidly growing specialist contract research organisation (CRO) and world leader in testing infectious and respiratory disease products using human challenge clinical trials, saw the share price rise which was then picked up in the Daily Mail Stock Watch this morning   For further information please contact:   hVIVO plc +44 (0) 20 7756 1300 Yamin ‘Mo’ Khan, Chief Executive Officer Stephen Pinkerton, Chief Financial Officer Liberum…

Continue reading

#HVO hVIVO PLC- £13.6m RSV antiviral contract November 10, 2022 – Posted in: Open Orphan (ORPH)

hVIVO plc (AIM & Euronext: HVO) (formerly Open Orphan plc), a rapidly growing specialist contract research organisation (CRO) and world leader in testing infectious and respiratory disease products using human challenge clinical trials, announces that it has signed a £13.6m contract with a US-based biopharmaceutical client to test its respiratory syncytial virus (“RSV”) antiviral candidate, using hVIVO’s established RSV Human Challenge Study Model                                 The Phase 2a double-blinded placebo-controlled human challenge trial will take place at…

Continue reading

BRR Media – Open Orphan #ORPH introduces Professor John Oxford February 7, 2020 – Posted in: Open Orphan (ORPH)

BRR Media introduces Open Orphan’s Professor John Oxford, consultant to the company and Virology expert. He discusses virology, and looks at recent virus epidemics, including influenza, AIDS, SARS and now Coronavirus. He explains how the hHIVO quarantine unit could play a key role in defeating Coronavirus…”This group (Open Orphan) is perfectly positioned, probably like no other, to move virology forward…particularly respiratory virology..” Click on the image to watch

Continue reading

Sunday Times – Irish firm Open Orphan #ORPH lined up for role in coronavirus fight February 2, 2020 – Posted in: Open Orphan (ORPH)

by Brian Carey An Irish company is on call to play a part in the fight against the spread of the Wuhan coronavirus. Open Orphan, which is listed on the Alternative Investment Market in London, has just completed the purchase of hVivo, a British company which owns the largest commercial quarantine clinic in northern Europe. The 24-bed clinic, attached to St Mary’s Hospital in London, is the only purpose-built commercial quarantine facility of its kind…

Continue reading

Open Orphan #ORPH – Results of Placing and Subscription January 31, 2020 – Posted in: Open Orphan (ORPH)

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS NOT FOR PUBLICATION, RELEASE OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES OF AMERICA, CANADA, AUSTRALIA, NEW ZEALAND, THE REPUBLIC OF SOUTH AFRICA OR JAPAN OR IN OR INTO ANY OTHER JURISDICTION WHERE TO DO SO WOULD BREACH ANY APPLICABLE LAW OR REGULATION. THIS ANNOUNCEMENT IS FOR INFORMATION PURPOSES ONLY AND DOES NOT ITSELF CONSTITUTE AN OFFER FOR SALE…

Continue reading

Open Orphan (ORPH) – Proposed Placing to raise a minimum of £5 million to fund growth and convert hVIVO proposal pipeline – Posted in: Open Orphan (ORPH)

THIS ANNOUNCEMENT (INCLUDING THE APPENDICES) AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR PUBLICATION, RELEASE OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES OF AMERICA, CANADA, AUSTRALIA, NEW ZEALAND, THE REPUBLIC OF SOUTH AFRICA OR JAPAN OR IN OR INTO ANY OTHER JURISDICTION WHERE TO DO SO WOULD BREACH ANY APPLICABLE LAW OR REGULATION. THIS ANNOUNCEMENT (INCLUDING THE APPENDICES) IS FOR INFORMATION PURPOSES ONLY…

Continue reading